AMERISAFE (NASDAQ: AMSF) director receives 2,340-share restricted stock grant

Rhea-AI Filing Summary

AMERISAFE, Inc. director Teri G. Fontenot reported an equity award of common stock. She acquired 2,340 shares of common stock at a stated price of $0.00 per share as a grant, not an open-market purchase.

The award is subject to restrictions that will lapse at the time of AMERISAFE's 2027 annual meeting of shareholders. After this grant, Fontenot directly holds 14,008 shares of AMERISAFE common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Fontenot Teri G.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common stock, par value $0.01	2,340	$0.00	--

Holdings After Transaction: Common stock, par value $0.01 — 14,008 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Equity award size: 2,340 shares Grant price per share: $0.00 per share Holdings after transaction: 14,008 shares +1 more

4 metrics

Equity award size 2,340 shares Grant of common stock to director on June 10, 2026

Grant price per share $0.00 per share Stated price for awarded common stock

Holdings after transaction 14,008 shares Director’s direct ownership after the grant

Restriction lapse event 2027 annual meeting Restrictions end at issuer’s 2027 annual meeting of shareholders

Key Terms

Grant, award, or other acquisition, Common stock, par value $0.01, annual meeting of shareholders, restricted shares

4 terms

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Common stock, par value $0.01 financial

"security_title: Common stock, par value $0.01"

annual meeting of shareholders regulatory

"restrictions will lapse at the time of the Issuer's 2027 annual meeting of shareholders"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

restricted shares financial

"Subject to restrictions that will lapse at the time of the Issuer's 2027 annual meeting"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fontenot Teri G.

(Last) (First) (Middle)

18933 EAST PINNACLE CIRCLE

(Street)

BATON ROUGE LOUISIANA 70810

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMERISAFE INC [ AMSF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, par value $0.01	06/10/2026		A		2,340(1)	A	$0	14,008	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Subject to restrictions that will lapse at the time of the Issuer's 2027 annual meeting of shareholders.

	/s/ Kathryn H. Shirley, attorney-in-fact for Teri G. Fontenot	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did AMERISAFE (AMSF) report for Teri G. Fontenot?

AMERISAFE reported that director Teri G. Fontenot received an equity grant of 2,340 shares of common stock. The Form 4 shows this as a grant or award acquisition, rather than an open-market purchase or sale, reflecting routine director compensation in stock.

How many AMERISAFE (AMSF) shares were granted to Teri G. Fontenot and at what price?

Teri G. Fontenot was granted 2,340 shares of AMERISAFE common stock at a stated price of $0.00 per share. This indicates a compensation-related stock award, not a cash purchase, consistent with typical director equity compensation programs at many public companies.

What restrictions apply to Teri G. Fontenot’s new AMERISAFE (AMSF) shares?

The granted 2,340 AMERISAFE shares are subject to restrictions that will lapse at the time of the company’s 2027 annual meeting of shareholders. Until then, the award remains restricted, commonly limiting transferability or vesting before that meeting occurs.

How many AMERISAFE (AMSF) shares does Teri G. Fontenot hold after this Form 4 transaction?

After the grant, Teri G. Fontenot directly holds 14,008 shares of AMERISAFE common stock. This total includes the newly awarded 2,340 restricted shares and represents her direct ownership reported in the Form 4 following the compensation-related stock grant.

Was the AMERISAFE (AMSF) Form 4 transaction a stock purchase or sale on the market?

The Form 4 shows a grant or award acquisition, not a market trade. The 2,340 shares were received at a stated price of $0.00 per share, reflecting equity compensation rather than an open-market buy or sell transaction by director Teri G. Fontenot.

What role does Teri G. Fontenot hold at AMERISAFE (AMSF)?

Teri G. Fontenot is identified as a director of AMERISAFE, Inc. in the Form 4. The reported transaction reflects director-level equity compensation, aligning her interests with shareholders through additional restricted common stock rather than a cash-based payment.